Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma

New England Journal of Medicine

Volumn 324, Issue 4, 1991, Pages 219-226

  Moss, Thomas J ^a   Reynolds, C Patrick ^a   Sather, Harland N ^a   Seeger, Robert C ^a   Hammond, G Denman ^b   Romansky, Stephen G ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BONE MARROW; CYTOLOGY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; NEUROBLASTOMA; PRIORITY JOURNAL; PROGNOSIS;

AGE FACTORS; ANTIBODIES, MONOCLONAL; BIOPSY; BONE MARROW; COMPARATIVE STUDY; HUMAN; IMMUNOENZYME TECHNIQUES; NEOPLASM METASTASIS; NEOPLASM STAGING; NEUROBLASTOMA; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TREPHINING; TUMOR CELLS, CULTURED;

EID: 0026081803     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199101243240403     Document Type: Article

References (56)

1. Young L.L. Jr. Miller RW. Incidence of malignant tumors in U.S. children. J Pediatr 1975; 86:254-258
2. Reynolds C.P., Selch M.T., Seeger R.C. Neuroblastoma. In: Haskell CM, ed. Cancer treatment. 3rd ed. Philadelphia: W.B. Saunders, 1990: 489-99.
3. Breslow N., McCann B. Statistical estimation of prognosis for children with neuroblastoma. Cancer Res 1971; 31:2098-2103
4. Evans A.E., Albo V., D#x0027;Angio G.J., et al. Factors influencing survival of children with nonmetastatic neuroblastoma. Cancer 1976; 38:661-666
5. Nitschke R., Smith E.I., Shochat S., et al. Localized neuroblastoma treated by surgery: a Pediatric Oncology Group Study. J Clin Oncol 1988; 6:1271-1279
6. Evans A.E., Baum E., Chard R. Do infants with stage IV-S neuroblastoma need treatment? Arch Dis Child 1981; 56:271-274
7. Seeger R.C., Brodeur G.M., Sather H., et al. Association of multiple copies of N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 1985; 313:1111-1116
8. Evans A.E., D#x0027;Angio G.J., Propert K., Anderson J., Hann H.W. Prognostic factor in neuroblastoma. Cancer 1987; 59:1853-1859
9. Zeltzer P.M., Marangos P.J., Parma A.M., et al. Raised neuron-specific enolase in serum of children with metastatic neuroblastoma. Lancet 1983; 2:361-363
10. Hann H.W., Evans A.E., Siegel S.E., et al. Prognostic importance of serum ferritin in patients with stages III and IV neuroblastoma: the Childrens Cancer Study Group experience. Cancer Res 1985; 45:2843-2848
11. Shimada H., Chatten J., Newton W.A. Jr., et al. Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst 1984; 73:405-416
12. Look A.T., Hayes F.A., Nitschke R., McWilliams N.B., Green A.A. Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma. N Engl J Med 1984; 311:231-235
13. Franklin I., Pritchard J. Detection of bone marrow invasion by neuroblastoma is improved by sampling at two sites with both aspirates and trephine biopsies. J Clin Pathol 1983; 36:1215-1218
14. Stephenson S.R., Cook B.A., Mease A.D., Ruymann F.B. The prognostic significance of age and pattern of metastases in stage IV-S neuroblastoma. Cancer 1986; 58:372-375
15. Moss T.J., Seeger R.C., Kindler-Rohrborn A., Marangos P.J., Rajewsky M.F., Reynolds C.P. Immunohistologic detection and phenotyping of neuroblastoma cells in bone marrow using cytoplasmic neuron specific enolase and cell surface antigens. In: Evans AE, D#x0027;Angio GJ, Seeger RC, eds. Advances in neuroblastoma research. Vol. 175 of Progress in clinical and biological research. New York: Alan R. Liss, 1985: 367-78.
16. Moss T.J., Rosenblatt H.R., Seeger R.C. Expression of a developmental stage-specific antigen by neuronal precursor cells of human fetal cerebellum. J Neuroimmunol 1988; 20:3-14.
17. Seeger R.C., Danon Y.L., Rayner S.A., Hoover F. Definition of a Thy-1 determinant on human neuroblastoma, glioma, sarcoma, and teratoma cells with a monoclonal antibody. J Immunol 1982; 128:983-989
18. Smith R.G., Reynolds C.P. Monoclonal antibody recognizing a human neuroblastoma-associated antigen. Diag Clin Immunol 1987; 5:209-220
19. Schulz G., Cheresh D.A., Varki N.M., Yu A., Staffileno L.K., Resfeld R.A. Detection of ganglioside GD2 in tumor tissues and sera of neuroblastoma patients. Cancer Res 1984; 44:5914-5920
20. Seeger R.C., Rayner S.A., Banerjee A., et al. Morphology, growth, chromosomal pattern and fibrinolytic activity of two new human neuroblastoma cell lines. Cancer Res 1977; 37:1364-1371
21. Reynolds C.P., Biedler J.L., Spengler B.A., et al. Characterization of human neuroblastoma cell lines established before and after therapy. J Natl Cancer Inst 1986; 76:375-387
22. Evans A.E., D#x0027;Angio G.J., Randolph J. A proposed staging for children with neuroblastoma. Cancer 1971; 27:374-378
23. Reynolds C.P., Moss T.J., Seeger R.C., Black A.T., Woody J.N. Sensitive detection of neuroblastoma cells in bone marrow for monitoring the efficacy of marrow purging procedures. In: Evans AE, D#x0027;Angio GJ, Seeger RC, eds. Advances in neuroblastoma research. Vol. 175 of Progress in clinical and biological research. New York: Alan R. Liss, 1985: 425-41.
24. Hsu S.M., Raine L., Fanger H. Use of avidin–biotin–peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981; 29:577-580
25. Fleiss J. Statistical methods for rates and proportions. New York: John Wiley, 1973: 72-7.
26. Hollander M., Wolfe D.A. Nonparametric statistical methods. New York: John Wiley, 1973: 67-75, 114-9.
27. Cox D.R. Regression models and life-tables. J R Stat Soc [B] 1972; 34:187-220.
28. Peto R., Pike M., Armitage P., et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977; 35:1-39.
29. Jonak Z.L., Kennett R.H., Bechtol K.B. Detection of neuroblastoma cells in human bone marrow using a combination of monoclonal antibodies. Hybridoma 1982; 1:349-368
30. Evans A.E., Griffin G.C., Tartaglione M., Kennett R.H. A method of detecting neuroblastoma in human bone marrow by means of two monoclonal antibodies PI 153/3 and KE2. Hybridoma 1985; 4:289-296
31. Cheung N.K., Van Hoff D.D., Strandjord S.E., Coccia P.F. Detection of neuroblastoma cells in bone marrow using GD2 specific monoclonal antibodies. J Clin Oncol 1986; 4:363-369
32. Favrot M.C., Frappaz D., Maritaz O., et al. Histological, cytological and immunological analyses are complementary for the detection of neuroblastoma cells in bone marrow. Br J Cancer 1986; 54:637-641
33. Beck D., Maritaz O., Gross N., et al. Immunocytochemical detection of neuroblastoma cells infiltrating clinical bone marrow samples. Eur J Pediatr 1988; 147:609-612
34. Combaret V., Favrot M.C., Kremens B., et al. Immunological detection of neuroblastoma cells in bone marrow harvested for autologous transplantation. Br J Cancer 1989; 59:844-847
35. Oppedal B.R., Storm-Methisen I., Kemshead J.T., Brandtzaeg P. Bone marrow examination in neuroblastoma patients: a morphologic, immunocytochemical, and immunohistochemical study. Hum Pathol 1989; 20:800-805
36. Rogers D.W., Treleaven J.G., Kemshead J.T., Pritchard J. Monoclonal antibodies for detecting bone marrow invasion by neuroblastoma. J Clin Pathol 1989; 42:422-426
37. Reynolds C.P., Seeger R.C., Vo D.D., Black A.T., Wells J., Ugelstad J. Model system for removing neuroblastoma cells from bone marrow using monoclonal antibodies and magnetic immunobeads. Cancer Res 1986; 46:5882-5886
38. Bayle C., Allard T., Rodary C., et al. Detection of bone marrow involvement by neuroblastoma: comparison of two cytological methods. Eur Paediatr Haematol Oncol 1985; 2:123-128
39. Bostrom B., Nesbit M.E. Jr., Brunning R.D. The value of bone marrow trephine biopsy in the diagnosis of metastatic neuroblastoma. Am J Pediatr Hematol Oncol 1985; 7:303-305
40. Mills A.E., Bird A.R. Bone marrow changes in neuroblastoma. Pediatr Pathol 1986; 5:225-234
41. Hartmann O., Benhamou E., Beaujean F., et al. High-dose busulfan and cyclophosphamide with autologous bone marrow transplantation support in advanced malignancies in children: a phase II study. J Clin Oncol 1986; 4:1804-1810
42. Hartmann O., Kalifa C., Benhamou E., et al. Treatment of advanced neuroblastoma with high-dose melphalan and autologous bone marrow transplantation. Cancer Chemother Pharmacol 1986; 16:165-169
43. Seeger R.C., Reynolds C.P., Moss T.J., et al. Autologous bone marrow transplantation for poor-prognosis neuroblastoma. In: Dicke KA, Spitzer G, Jagannath S, eds. Autologous marrow transplantation: proceedings of the Third International Symposium. Houston: MD Anderson Press, 1987: 375-82.
44. Philip T., Bernard J.L., Zucker J.M., et al. High dose chemoradiotherapy with bone marrow transplantation as consolidation treatment in neuroblastoma: an unselected group of stage IV patients over 1 year of age. J Clin Oncol 1987; 5:266-271
45. Hartmann O., Benhamou E., Beaujean F., et al. Repeated high-dose chemotherapy followed by purged autologous bone marrow transplantation as consolidation therapy in metastatic neuroblastoma. J Clin Oncol 1987; 5:1205-1211
46. Redding W.H., Coombes R.C., Monaghan P., et al. Detection of micrometastases in patients with primary breast cancer. Lancet 1983; 2:1271-1274
47. Stahel R.A., Mabry M., Skarin A.T., Speak J., Bernai S.D. Detection of bone marrow metastasis in small-cell lung cancer by monoclonal antibody. J Clin Oncol 1985; 3:455-461
48. Ghosh A.K., Erber W.N., Hatton C.S.R., et al. Detection of metastatic tumour cells in routine bone marrow smears by immuno-alkaline phosphatase labeling with monoclonal antibodies. Br J Haematol 1985; 61:21-30.
49. Frew A.J., Ralfkiaer N., Ghosh A.K., Gatter K.C., Mason D.Y. Immunocyto-chemistry in the detection of bone marrow metastases in patients with primary lung cancer. Br J Cancer 1986; 53:555-556
50. Porro G., Menard S., Tagliabue E., et al. Monoclonal antibody detection of carcinoma cells in bone marrow biopsy specimens from breast cancer patients. Cancer 1988; 61:2407-2411
51. Canon J.L., Humblet Y., Lebacq-Verheyden A.M., et al. Immunodetection of small cell lung cancer metastases in bone marrow using three monoclonal antibodies. Eur J Cancer Clin Oncol 1988; 24:147-150
52. Berger U., Bettelheim R., Mansi J.L., Easton D., Coombes R.C., Neville A.M. The relationship between micrometastases in the bone marrow, histopathologic features of the primary tumor in breast cancer and prognosis. Am J Clin Pathol 1988; 90:1-6.
53. Osborne M.P., Asina S., Wong G.Y., Old L.J., Cote R.J. lmmunofluorescent monoclonal antibody detection of breast cancer in bone marrow: sensitivity in a model system. Cancer Res 1989; 49:2510-2513
54. Mansi J.L., Berger U., McDonnell T., et al. The fate of bone marrow micrometastases in patients with primary breast cancer. J Clin Oncol 1989; 7:445-449
55. Taha M., Ordonez N.G., Kulkami S., et al. A monoclonal antibody cocktail for detection of micrometastatic tumor cells in the bone marrow of breast cancer patients. Bone Marrow Transplant 1989; 4:297-303.
56. Joshi S.S., Kessinger A., Mann S.L., et al. Detection of malignant cells in histologically normal bone marrow using culture techniques. Bone Marrow Transplant 1987; 1:303-310